Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex for Reversal of Neuromuscular Blockade
NCT02860507Phase 4Completed
- Sponsor
- University of South Florida
- Start
- Aug 2016
- Primary completion
- Feb 2018
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by University of South Florida. Started Aug 2016; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02860507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02860507.